Literature DB >> 25484253

Nicotine and ethanol cooperate to enhance ventral tegmental area AMPA receptor function via α6-containing nicotinic receptors.

Staci E Engle1, J Michael McIntosh2, Ryan M Drenan3.   

Abstract

Nicotine + ethanol co-exposure results in additive and/or synergistic effects in the ventral tegmental area (VTA) to nucleus accumbens (NAc) dopamine (DA) pathway, but the mechanisms supporting this are unclear. We tested the hypothesis that nAChRs containing α6 subunits (α6* nAChRs) are involved in the response to nicotine + ethanol co-exposure. Exposing VTA slices from C57BL/6 WT animals to drinking-relevant concentrations of ethanol causes a marked enhancement of α-amino-3-hydroxy-5-methyl-isoxazolepropionic acid (AMPA) receptor (AMPAR) function in VTA neurons. This effect was sensitive to α-conotoxin MII (an α6β2* nAChR antagonist), suggesting that α6* nAChR function is required. In mice expressing hypersensitive α6* nAChRs (α6L9S mice), we found that lower concentrations (relative to C57BL/6 WT) of ethanol were sufficient to enhance AMPAR function in VTA neurons. Exposure of live C57BL/6 WT mice to ethanol also produced AMPAR functional enhancement in VTA neurons, and studies in α6L9S mice strongly suggest a role for α6* nAChRs in this response. We then asked whether nicotine and ethanol cooperate to enhance VTA AMPAR function. We identified low concentrations of nicotine and ethanol that were capable of strongly enhancing VTA AMPAR function when co-applied to slices, but that did not enhance AMPAR function when applied alone. This effect was sensitive to both varenicline (an α4β2* and α6β2* nAChR partial agonist) and α-conotoxin MII. Finally, nicotine + ethanol co-exposure also enhanced AMPAR function in VTA neurons from α6L9S mice. Together, these data identify α6* nAChRs as important players in the response to nicotine + ethanol co-exposure in VTA neurons.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Addiction; Alcohol; Co-exposure; Dopamine; Glutamate; Nicotine

Mesh:

Substances:

Year:  2014        PMID: 25484253      PMCID: PMC4312744          DOI: 10.1016/j.neuropharm.2014.11.014

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  73 in total

1.  Nicotinic cholinergic mechanisms causing elevated dopamine release and abnormal locomotor behavior.

Authors:  B N Cohen; E D W Mackey; S R Grady; S McKinney; N E Patzlaff; C R Wageman; J M McIntosh; M J Marks; H A Lester; R M Drenan
Journal:  Neuroscience       Date:  2011-11-04       Impact factor: 3.590

2.  Acute and chronic cocaine-induced potentiation of synaptic strength in the ventral tegmental area: electrophysiological and behavioral correlates in individual rats.

Authors:  Stephanie L Borgland; Robert C Malenka; Antonello Bonci
Journal:  J Neurosci       Date:  2004-08-25       Impact factor: 6.167

3.  Chronic nicotine cell specifically upregulates functional alpha 4* nicotinic receptors: basis for both tolerance in midbrain and enhanced long-term potentiation in perforant path.

Authors:  Raad Nashmi; Cheng Xiao; Purnima Deshpande; Sheri McKinney; Sharon R Grady; Paul Whiteaker; Qi Huang; Tristan McClure-Begley; Jon M Lindstrom; Cesar Labarca; Allan C Collins; Michael J Marks; Henry A Lester
Journal:  J Neurosci       Date:  2007-08-01       Impact factor: 6.167

4.  SNPs in CHRNA6 and CHRNB3 are associated with alcohol consumption in a nationally representative sample.

Authors:  N R Hoft; R P Corley; M B McQueen; D Huizinga; S Menard; M A Ehringer
Journal:  Genes Brain Behav       Date:  2009-03-23       Impact factor: 3.449

Review 5.  Comorbid cigarette and alcohol addiction: epidemiology and treatment.

Authors:  N S Miller; M S Gold
Journal:  J Addict Dis       Date:  1998

6.  A novel mechanism for nicotinic potentiation of glutamatergic synapses.

Authors:  Andrew W Halff; David Gómez-Varela; Danielle John; Darwin K Berg
Journal:  J Neurosci       Date:  2014-02-05       Impact factor: 6.167

7.  Nicotine persistently activates ventral tegmental area dopaminergic neurons via nicotinic acetylcholine receptors containing α4 and α6 subunits.

Authors:  Liwang Liu; Rubing Zhao-Shea; J Michael McIntosh; Paul D Gardner; Andrew R Tapper
Journal:  Mol Pharmacol       Date:  2012-01-05       Impact factor: 4.436

8.  Nicotine potentiation of excitatory inputs to ventral tegmental area dopamine neurons.

Authors:  Danyan Mao; Keith Gallagher; Daniel S McGehee
Journal:  J Neurosci       Date:  2011-05-04       Impact factor: 6.167

9.  Pharmacological profile of the alpha4beta2 nicotinic acetylcholine receptor partial agonist varenicline, an effective smoking cessation aid.

Authors:  H Rollema; L K Chambers; J W Coe; J Glowa; R S Hurst; L A Lebel; Y Lu; R S Mansbach; R J Mather; C C Rovetti; S B Sands; E Schaeffer; D W Schulz; F D Tingley; K E Williams
Journal:  Neuropharmacology       Date:  2006-12-08       Impact factor: 5.250

10.  Cholinergic modulation of locomotion and striatal dopamine release is mediated by alpha6alpha4* nicotinic acetylcholine receptors.

Authors:  Ryan M Drenan; Sharon R Grady; Andrew D Steele; Sheri McKinney; Natalie E Patzlaff; J Michael McIntosh; Michael J Marks; Julie M Miwa; Henry A Lester
Journal:  J Neurosci       Date:  2010-07-21       Impact factor: 6.167

View more
  13 in total

1.  Memantine Can Reduce Ethanol-Induced Caspase-3 Activity and Apoptosis in H4 Cells by Decreasing Intracellular Calcium.

Authors:  Xiaolong Wang; Jiajun Chen; Hongbo Wang; Hao Yu; Changliang Wang; Jiabin You; Pengfei Wang; Chunmei Feng; Guohui Xu; Xu Wu; Rui Zhao; Guohua Zhang
Journal:  J Mol Neurosci       Date:  2017-07-20       Impact factor: 3.444

Review 2.  The role of nicotinic acetylcholine receptors in alcohol-related behaviors.

Authors:  C N Miller; H M Kamens
Journal:  Brain Res Bull       Date:  2020-07-22       Impact factor: 4.077

Review 3.  Titrating Tipsy Targets: The Neurobiology of Low-Dose Alcohol.

Authors:  Changhai Cui; George F Koob
Journal:  Trends Pharmacol Sci       Date:  2017-03-31       Impact factor: 14.819

4.  Varenicline decreases nicotine but not alcohol self-administration in genetically selected Marchigian Sardinian alcohol-preferring (msP) rats.

Authors:  Giulia Scuppa; Andrea Cippitelli; Lawrence Toll; Roberto Ciccocioppo; Massimo Ubaldi
Journal:  Drug Alcohol Depend       Date:  2015-09-08       Impact factor: 4.492

5.  The Nicotinic α6-Subunit Selective Antagonist bPiDI Reduces Alcohol Self-Administration in Alcohol-Preferring Rats.

Authors:  Jirawoot Srisontiyakul; Hanna E Kastman; Elena V Krstew; Piyarat Govitrapong; Andrew J Lawrence
Journal:  Neurochem Res       Date:  2016-08-29       Impact factor: 3.996

6.  Voluntary co-consumption of alcohol and nicotine: Effects of abstinence, intermittency, and withdrawal in mice.

Authors:  Kyu Y O'Rourke; Jillienne C Touchette; Elizabeth C Hartell; Elizabeth J Bade; Anna M Lee
Journal:  Neuropharmacology       Date:  2016-06-21       Impact factor: 5.250

7.  α6-Containing nicotinic acetylcholine receptors in midbrain dopamine neurons are poised to govern dopamine-mediated behaviors and synaptic plasticity.

Authors:  J N Berry; S E Engle; J M McIntosh; R M Drenan
Journal:  Neuroscience       Date:  2015-07-23       Impact factor: 3.590

Review 8.  Critical needs in drug discovery for cessation of alcohol and nicotine polysubstance abuse.

Authors:  C E Van Skike; S E Maggio; A R Reynolds; E M Casey; M T Bardo; L P Dwoskin; M A Prendergast; K Nixon
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2015-11-12       Impact factor: 5.067

9.  Altered nicotine reward-associated behavior following α4 nAChR subunit deletion in ventral midbrain.

Authors:  Can Peng; Staci E Engle; Yijin Yan; Marcus M Weera; Jennifer N Berry; Matthew C Arvin; Guiqing Zhao; J Michael McIntosh; Julia A Chester; Ryan M Drenan
Journal:  PLoS One       Date:  2017-07-31       Impact factor: 3.240

10.  Nicotine enhances alcohol intake and dopaminergic responses through β2* and β4* nicotinic acetylcholine receptors.

Authors:  Stefania Tolu; Fabio Marti; Carole Morel; Carole Perrier; Nicolas Torquet; Stephanie Pons; Renaud de Beaurepaire; Philippe Faure
Journal:  Sci Rep       Date:  2017-03-23       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.